DMC100371
Anti-GPC3 antibody(DMC371); IgG1 Chimeric mAb

Größe
£198.00
- SKU:
- DMC100371
- Zusätzliche Namen:
- DGSX; GTR2-2; MXR7; OCI-5; SDYS; SGB; SGBS; SGBS1
- Anwendung:
- Flow Cytometry
- Aufreinigung:
- Purified from cell culture supernatant by affinity chromatography
- Lagerbedingungen:
- Store at -20[o]C to -80[o]C for 12 months in lyophilized form. After reconstitution; if not intended for use within a month; aliquot and store at -80[o]C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
- Hersteller:
- DIMA Biotechnology Ltd
- Host:
- Rabbit
- Reaktivitäten:
- Human
- Formulierung:
- Lyophilized from sterile PBS; pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution.
- Klon:
- DMC371
- Target:
- GPC3
- Weitere Details:
- Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation. The protein encoded by this gene can bind to and inhibit the dipeptidyl peptidase activity of CD26; and it can induce apoptosis in certain cell types. Deletion mutations in this gene are associated with Simpson-Golabi-Behmel syndrome; also known as Simpson dysmorphia syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq; Sep 2009] References: Fu Ying;Urban Daniel J;Nani Roger R et al. Glypican-3-Specific Antibody Drug Conjugates Targeting Hepatocellular Carcinoma.[J] .Hepatology; 2019; 70: 563-576. Zhang Yi-Fan;Ho Mitchell;Humanization of high-affinity antibodies targeting glypican-3 in hepatocellular carcinoma.
- Versandbedingungen:
- Ambient
